Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Common Equity (2016 - 2025)

cbdMD's Common Equity history spans 10 years, with the latest figure at $9.0 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 405.61% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 405.61% increase, with the full-year FY2025 number at $7.2 million, up 268.04% from a year prior.
  • Common Equity hit $9.0 million in Q4 2025 for cbdMD, up from $7.2 million in the prior quarter.
  • Over the last five years, Common Equity for YCBD hit a ceiling of $103.1 million in Q3 2021 and a floor of $665798.0 in Q1 2025.
  • Historically, Common Equity has averaged $32.4 million across 5 years, with a median of $17.4 million in 2023.
  • Biggest five-year swings in Common Equity: plummeted 88.23% in 2024 and later skyrocketed 405.61% in 2025.
  • Tracing YCBD's Common Equity over 5 years: stood at $84.4 million in 2021, then tumbled by 68.49% to $26.6 million in 2022, then crashed by 73.54% to $7.0 million in 2023, then crashed by 74.68% to $1.8 million in 2024, then skyrocketed by 405.61% to $9.0 million in 2025.
  • Business Quant data shows Common Equity for YCBD at $9.0 million in Q4 2025, $7.2 million in Q3 2025, and $6.1 million in Q2 2025.